AGL logo

agilon health inc. (AGL)

$0.43

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on AGL

Market cap

$179929014

EPS

-0.75

P/E ratio

--

Price to sales

0.03

Dividend yield

--

Beta

0.065035

Price on AGL

Previous close

$0.44

Today's open

$0.44

Day's range

$0.40 - $0.44

52 week range

$0.34 - $6.08

Profile about AGL

CEO

Steven J. Sell

Employees

1076

Headquarters

Westerville, OH

Exchange

New York Stock Exchange

Shares outstanding

414869759

Issue type

Common Stock

AGL industries and sectors

Healthcare

Healthcare Providers & Services

News on AGL

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against agilon health, inc. (NYSE: AGL)

Agilon Health Shareholders Between February 26, 2025 and August 4, 2025 - Contact Bernstein Liebhard For More Information Regarding Shareholder Lawsuit

news source

GlobeNewsWire • 14 hours ago

news preview

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in agilon health, inc. of Class Action Lawsuit and Upcoming Deadlines - AGL

NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against agilon health, inc. (“Agilon” or the “Company”) (NYSE: AGL). Such investors are advised to contact Danielle Peyton at [email protected]  or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

news source

GlobeNewsWire • 6 hours ago

news preview

AGILON DEADLINE MARCH 2nd: Bragar Eagel & Squire, P.C. Urgently Reminds Agilon Health Investors with Larges Losses to Contact the Firm Before the Lead Plaintiff Deadline

Bragar Eagel & Squire, P.C.  Litigation Partner  Brandon Walker  Encourages Investors Who Suffered Losses In Agilon (AGL) To Contact Him Directly To Discuss Their Options

news source

GlobeNewsWire • 5 hours ago

news preview

Portnoy Law Firm Announces Class Action on Behalf of agilon health, inc. Investors

LOS ANGELES, Feb. 24, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises agilon health, inc, (“agilon” or the "Company") (NYSE: AGL) investors off a class action on behalf of investors that bought securities between February 26, 2025 and August 4, 2025, inclusive (the “Class Period”). agilon investors have until March 2, 2026 to file a lead plaintiff motion.

news source

GlobeNewsWire • 12 hours ago

news preview

Bronstein, Gewirtz & Grossman LLC Urges agilon health, inc. Investors to Act: Class Action Filed Alleging Investor Harm

New class action for agilon (AGL) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of Mar. 2, 2026.

news source

GlobeNewsWire • 11 hours ago

news preview

AGILON DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages agilon health, inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AGL

NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of agilon health, inc. (NYSE: AGL) between February 26, 2025 and August 4, 2025, both dates inclusive (the “Class Period”), of the important March 2, 2026 lead plaintiff deadline in the securities class action first filed by the Firm.

news source

GlobeNewsWire • 7 hours ago

news preview

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 2, 2026 in agilon health, inc. Lawsuit - AGL

NEW YORK, Feb. 24, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of agilon health, inc. (NYSE: AGL).

news source

PRNewsWire • 14 hours ago

news preview

AGL UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds agilon health (AGL) Investors of Securities Class Action Deadline on March 2, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Agilon health To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Agilon health between February 26, 2025 and August 4, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - February 24, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Agilon health, inc.

news source

Newsfile Corp • 2 hours ago

news preview

AGL Investors Have Opportunity to Lead agilon health, inc. Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES, Feb. 23, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against agilon health, inc. (“Agilon” or “the Company”) (NYSE: AGL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

news source

GlobeNewsWire • Feb 23, 2026

news preview

Levi & Korsinsky Reminds agilon health, inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 2, 2026 – AGL

NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in agilon health, inc. ("agilon health, inc." or the "Company") (NYSE: AGL) of a class action securities lawsuit.

news source

GlobeNewsWire • Feb 23, 2026

news preview

¹ Disclosures

Get started with M1

Invest in agilon health inc.

Open an M1 investment account to buy and sell agilon health inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in AGL on M1